Immune therapy

28 Jan 2020
09:35-10:55
Hall 5
Back

Immune therapy

TREATMENT RESPONSE AND TOXICITIES IN BREAST CANCER
Mark Harries

COMBINED ANALYSIS OF PDL1 AND TILs IN BREAST CANCER: THE NEW NARRATIVE IN DAILY PRACTICE?
Roberto Salgado

CHARACTERISING IMMUNE RESPONSE
Raza Ali

CHAIRS: Andrew Tutt & Adrienne Morgan